{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Berberis lycium", "MD simulation", "Medicinal plants", "pharmacokinetics", "viral infections"]], "OtherAbstract": [], "SpaceFlightMission": [], "InvestigatorList": [], "CitationSubset": [], "OtherID": [], "GeneralNote": [], "PMID": "39072259", "DateRevised": {"Year": "2024", "Month": "07", "Day": "30"}, "Article": {"Language": ["eng"], "ELocationID": ["11779322241264144", "10.1177/11779322241264144"], "ArticleDate": [{"Year": "2024", "Month": "07", "Day": "27"}], "Journal": {"ISSN": "1177-9322", "JournalIssue": {"Volume": "18", "PubDate": {"Year": "2024"}}, "Title": "Bioinformatics and biology insights", "ISOAbbreviation": "Bioinform Biol Insights"}, "ArticleTitle": "Computational Exploration of <i>Berberis lycium</i> Royle: A Hidden Treasure Trove for Antiviral Development.", "Pagination": {"StartPage": "11779322241264144", "MedlinePgn": "11779322241264144"}, "Abstract": {"AbstractText": ["Viral infections and associated illnesses account for approximately 3.5 million global fatalities and public health problems. Medicinal plants, with their wide therapeutic range and minimal side effects, have gained limelight particularly in response to growing concerns about drug resistance and sluggish development of antiviral drugs. This study computationally assessed 11 chemical compounds from <i>Berberis lycium</i> along with two antiviral drugs to inhibit SARS CoV 2 (coronavirus disease 2019 [COVID-19]) RNA-dependent RNA polymerase (RdRP), influenza virus RdRP, and two crucial dengue virus (DENV) enzymes (NS2B/NS3 protease and NS5 polymerase). Berberine and oxyberberine passed all pharmacokinetics analysis filters including Lipinski rule, blood-brain barrier permeant, and cytochrome suppression and demonstrated drug-likeness, bioavailability, and a non-toxic profile. Docking of phytochemicals from <i>B lycium</i> returned promising results with selected viral proteins, ie, DENV NS2BNS3 (punjabine -10.9 kcal/mol), DENV NS5 (punjabine -10.4 kcal/mol), COVID-19 RdRP (oxyacanthine -9.5 kcal/mol), and influenza RdRP (punjabine -10.4 kcal/mol). The optimal pharmacokinetics of berberine exhibited good binding energies with NS2BNS3 (-8.0 kcal/mol), NS5 (-8.3 kcal/mol), COVID RdRP (-7.7 kcal/mol), and influenza RdRP (-8.3 kcal/mol), while molecular dynamics simulation of a 50-ns time scale by GROMACS software package provided insights into the flexibility and stability of the complexes. A hidden treasure trove for antiviral research, berberine, berbamine, berbamunine, oxyberberine, oxyacanthine, baluchistanamine, and sindamine has showed encouraging findings as possible lead compounds. Pharmacological analyses provide credence for the proposed study; nevertheless, as the antiviral mechanisms of action of these phytochemicals are not well understood, additional research and clinical trials are required to demonstrate both their efficacy and toxicity through in vitro and in vivo studies."], "CopyrightInformation": "\u00a9 The Author(s) 2024."}, "AuthorList": [{"Identifier": ["0000-0002-5363-7342"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Industrial Biotechnology, Atta ur Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan."}], "LastName": "Mukhtar", "ForeName": "Mamuna", "Initials": "M"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Industrial Biotechnology, Atta ur Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Biotechnology, University of Mianwali, Mianwali, Pakistan."}], "LastName": "Khan", "ForeName": "Haris Ahmed", "Initials": "HA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Microbiology, School of Life Sciences, The Federal University of Technology Akure, Akure, Nigeria."}], "LastName": "Ibisanmi", "ForeName": "Tope Abraham", "Initials": "TA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Chemistry, School of Physical Sciences, The Federal University of Technology Akure, Akure, Nigeria."}], "LastName": "Faleti", "ForeName": "Ayodele Ifeoluwa", "Initials": "AI"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Industrial Biotechnology, Atta ur Rahman School of Applied Biosciences, National University of Sciences and Technology, Islamabad, Pakistan."}, {"Identifier": [], "Affiliation": "Department of Biological and Health Sciences, Pak-Austria Fachhochschule: Institute of Applied Sciences and Technology, Mang, Haripur-KPK, Pakistan."}], "LastName": "Zaidi", "ForeName": "Najam Us Sahar Sadaf", "Initials": "NUSS"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Bioinform Biol Insights", "NlmUniqueID": "101467187", "ISSNLinking": "1177-9322"}, "CoiStatement": "The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article."}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "Adamson CS, Chibale K, Goss RJ, Jaspars M, Newman DJ, Dorrington RA. Antiviral drug discovery: preparing for the next pandemic. Chem Soc Rev. 2021;50:3647-3655.", "ArticleIdList": ["33524090"]}, {"Citation": "Martinez JP, Sasse F, Br\u00f6nstrup M, Diez J, Meyerhans A. Antiviral drug discovery: broad-spectrum drugs from nature. Nat Prod Rep. 2015;32:29-48.", "ArticleIdList": ["25315648"]}, {"Citation": "Krishnan N, Devadasan V, Raman P. Plant-derived alkaloids as anti-viral agents. Int J Res Pharm Sci. 2020;11:6174-6182."}, {"Citation": "Abookleesh FL, Al-Anzi BS, Ullah A. Potential antiviral action of alkaloids. Molecules. 2022;27:903.", "ArticleIdList": ["PMC8839337", "35164173"]}, {"Citation": "Mohan S, Elhassan Taha MM, Makeen HA, et al.. Bioactive natural antivirals: an updated review of the available plants and isolated molecules. Molecules. 2020;25:4878.", "ArticleIdList": ["PMC7659943", "33105694"]}, {"Citation": "Mei M, Tan X. Current strategies of antiviral drug discovery for COVID-19. Front Mol Biosci. 2021;8:671263. doi:10.3389/fmolb.2021.671263", "ArticleIdList": ["10.3389/fmolb.2021.671263", "PMC8155633", "34055887"]}, {"Citation": "Ngwe Tun MM, Toume K, Luvai E, et al.. The discovery of herbal drugs and natural compounds as inhibitors of SARS-CoV-2 infection in vitro. J Nat Med. 2022;76:402-409.", "ArticleIdList": ["PMC8743439", "35006524"]}, {"Citation": "Patel H, Kukol A. Integrating molecular modelling methods to advance influenza A virus drug discovery. Drug Discov Today. 2021;26:503-510.", "ArticleIdList": ["33220433"]}, {"Citation": "Mukhtar M, Wajeeha AW, Bibi N. Engineering modified mRNA-based vaccine against dengue virus using computational and reverse vaccinology approaches. Int J Mol Sci. 2022;23:13911.", "ArticleIdList": ["PMC9698390", "36430387"]}, {"Citation": "Delang L, Abdelnabi R, Neyts J. Favipiravir as a potential countermeasure against neglected and emerging RNA viruses. Antiviral Res. 2018;153:85-94.", "ArticleIdList": ["29524445"]}, {"Citation": "Shiraki K, Daikoku T. Favipiravir, an anti-influenza drug against life-threatening RNA virus infections. Pharmacol Ther. 2020;209:107512.", "ArticleIdList": ["PMC7102570", "32097670"]}, {"Citation": "Hickman MR, Saunders DL, Bigger CA, Kane CD, Iversen PL. The development of broad-spectrum antiviral medical countermeasures to treat viral hemorrhagic fevers caused by natural or weaponized virus infections. PLoS Negl Trop Dis. 2022;16:e0010220.", "ArticleIdList": ["PMC8903284", "35259154"]}, {"Citation": "Dhama K, Karthik K, Khandia R, et al.. Medicinal and therapeutic potential of herbs and plant metabolites/extracts countering viral pathogens-current knowledge and future prospects. Curr Drug Metab. 2018;19:236-263.", "ArticleIdList": ["29380697"]}, {"Citation": "Bukhari SMF, Ali G. An overview of ethnobotany of Berberis lycium Royle in Pakistan. In: \u00d6zt\u00fcrk M, Khan SM, Altay V, Efe R, Egamberdieva D, Khassanov FO, eds. Biodiversity, Conservation and Sustainability in Asia. Springer; 2022:931-942."}, {"Citation": "Ahmad M, Alamgeer ST. A potential adjunct to insulin: Berberis lycium Royle. Diabetol Croat. 2009;38:13-18."}, {"Citation": "Rahimi Madiseh M, Heidarian E, Rafieian-Kopaei M. Biochemical components of Berberis lycium fruit and its effects on lipid profile in diabetic rats. J Herbmed Pharmacol. 2014;3:15-19."}, {"Citation": "Shabbir A, Shahza DN, Arfat Y. Berberis lycium Royle: a review of its traditional uses, phytochemistry and pharmacology. Afr J Pharm Pharmacol. 2012;6:2346-2353. doi:10.5897/ajpp12.927", "ArticleIdList": ["10.5897/ajpp12.927"]}, {"Citation": "Gupta M, Singh A, Joshi HC. Berberis lycium multipotential medicinal application: an overview. Int J Chem Stud. 2015;3:10-13."}, {"Citation": "Ahmad L, Ullah F, Semotiuk AJ, et al.. Traditional knowledge and economic significance of Berberis lycium Royle in the Lower Dir District, Pakistan. Ethnobot Res Appl. 2020;20:1-12."}, {"Citation": "Kapoor B, Sood P, Modgil R, Sood M. Berberis lycium a medicinal plant with immense value. Indian J Pharm Biol Res. 2013;1:27-37."}, {"Citation": "Ahsan Elahi Bukhari S, Mubashar Sabir S, Ali S, et al.. Antioxidant and enzyme inhibitory activities of Zizypus jujuba, Adhatoda vasica and Berberis lycium from hilly areas. J King Saud Univ Sci. 2022;34:101980. doi:10.1016/j.jksus.2022.101980", "ArticleIdList": ["10.1016/j.jksus.2022.101980"]}, {"Citation": "Matsuura HN, Fett-Neto AG. Plant alkaloids: main features, toxicity, and mechanisms of action. In: Gopalakrishnakone P, Carlini C, Ligabue-Braun R, eds. Plant Toxins. Springer; 2015:1-15."}, {"Citation": "Pereira GC, Branco AF, Matos JA, et al.. Mitochondrially targeted effects of berberine [natural yellow 18, 5, 6-dihydro-9, 10-dimethoxybenzo (g)-1, 3-benzodioxolo (5, 6-a) quinolizinium] on K1735-M2 mouse melanoma cells: comparison with direct effects on isolated mitochondrial fractions. J Pharmacol Exp Ther. 2007;323:636-649.", "ArticleIdList": ["17704354"]}, {"Citation": "Malik TA, Kamili AN, Chishti MZ, et al.. Breaking the resistance of Escherichia coli: antimicrobial activity of Berberis lycium Royle. Microb Pathog. 2017;102:12-20. doi:10.1016/j.micpath.2016.11.011", "ArticleIdList": ["10.1016/j.micpath.2016.11.011", "27888048"]}, {"Citation": "Shah SAH, Aleem A. Investigations of plausible pharmacodynamics supporting the antispasmodic, bronchodilator, and antidiarrheal activities of Berberis lycium Royle. Via in silico, in vitro, and in vivo studies. J Ethnopharmacol. 2023;305:116115.", "ArticleIdList": ["36587881"]}, {"Citation": "Bhalodia NR, Shukla VJ. Antibacterial and antifungal activities from leaf extracts of Cassia fistula L.: an ethnomedicinal plant. J Adv Pharm Technol Res. 2011;2:104-109.", "ArticleIdList": ["PMC3217694", "22171301"]}, {"Citation": "Ali S, Alam M, Khatoon F, et al.. Natural products can be used in therapeutic management of COVID-19: probable mechanistic insights. Biomed Pharmacother. 2022;147:112658.", "ArticleIdList": ["PMC8769927", "35066300"]}, {"Citation": "Piplani S, Singh P, Petrovsky N, Winkler DA. Computational repurposing of drugs and natural products against SARS-CoV-2 main protease (Mpro) as potential COVID-19 therapies. Front Mol Biosci. 2022;9:781039.", "ArticleIdList": ["PMC8964187", "35359601"]}, {"Citation": "Gulfraz M, Fatima N, Parveen Z, Mahmood S. Antimicrobial activity of Berberis lyceum Royle against different microorganisms. Can J Pure Appl Sci. 2007;1:15-20."}, {"Citation": "Mughal TA, Ali S, Hassan A, et al.. Phytochemical screening, antimicrobial activity, in vitro and in vivo antioxidant activity of Berberis lycium Royle root bark extract. Braz J Biol. 2022;84:e249742.", "ArticleIdList": ["35475988"]}, {"Citation": "Asif A, Kakub G, Mehmood S, Khunum R, Gulfraz M. Wound healing activity of root extracts of Berberis lyceum Royle in rats. Phytother Res. 2007;21:589-591.", "ArticleIdList": ["17295382"]}, {"Citation": "Ali H, Uddin S, Jalal S. Chemistry and biological activities of Berberis lyceum Royle. J Biol Act Prod Nat. 2015;5:295-312. doi:10.1080/22311866.2015.1073627", "ArticleIdList": ["10.1080/22311866.2015.1073627"]}, {"Citation": "Shruti A, Agarwal S, Dubey A, Verma A. Evaluation of in vitro anti-inflammatory activity in Berberis lyceum Royle of Shivalik range of Himalaya. Pharma Innov J. 2021;10:240-243."}, {"Citation": "Manavi MA. In silico study to identification of potential SARS-CoV-2 main protease inhibitors: virtual drug screening and molecular docking with AutoDock Vina and Molegro Virtual Docker. J Cell Mol Res. 2022;13:108-112."}, {"Citation": "Al-Ghani R, Nirwani WP, Novianti TN, Sari AGP. In silico anti-inflammatory activity evaluation from Usnea misaminensis through molecular docking approach. Chem Mater. 2022;1:77-82."}, {"Citation": "Ameji JP, Uzairu A, Shallangwa GA, Uba S. Design, pharmacokinetic profiling, and assessment of kinetic and thermodynamic stability of novel anti-Salmonella typhi imidazole analogues. Bull Natl Res Cent. 2023;47:6."}, {"Citation": "\u0160esti\u0107 TL, Ajdukovi\u0107 JJ, Marinovi\u0107 MA, Petri ET, Savi\u0107 MP. In silico ADMET analysis of the A-, B-and D-modified androstane derivatives with potential anticancer effects. Steroids. 2023;189:109147.", "ArticleIdList": ["36410412"]}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2012;64:4-17.", "ArticleIdList": ["11259830"]}, {"Citation": "Tabrez S, Hoque M, Suhail M, Khan MI, Zughaibi TA, Khan AU. Identification of anticancer bioactive compounds derived from Ficus sp. by targeting poly[ADP-ribose]polymerase 1 (PARP-1). J King Saud Univ Sci. 2022;34:102079."}, {"Citation": "Afza N, Fatma S, Ghous F, et al.. An efficient multicomponent synthesis, characterization, SAR, In-silico ADME prediction and molecular docking studies of 2-Amino-7-(substituted-phenyl)-3-cyano-4-phenyl-4, 5, 6, 7-tetrahydropyrano [2, 3-b] pyrrole-5-carboxylic acid derivatives and their in-vitro antimicrobial activity. J Mol Struct. 2023;1276:134721."}, {"Citation": "Pourhajibagher M, Bahador A. Virtual screening and computational simulation analysis of antimicrobial photodynamic therapy using propolis-benzofuran A to control of Monkeypox. Photodiagnosis Photodyn Ther. 2023;41:103208.", "ArticleIdList": ["PMC9675939", "36417972"]}, {"Citation": "Ghose AK, Viswanadhan VN, Wendoloski JJ. A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. J Comb Chem. 1999;1:55-68.", "ArticleIdList": ["10746014"]}, {"Citation": "Veber DF, Johnson SR, Cheng H-Y, Smith BR, Ward KW, Kopple KD. Molecular properties that influence the oral bioavailability of drug candidates. J Med Chem. 2002;45:2615-2623.", "ArticleIdList": ["12036371"]}, {"Citation": "Egan WJ, Merz KM, Baldwin JJ. Prediction of drug absorption using multivariate statistics. J Med Chem. 2000;43:3867-3877.", "ArticleIdList": ["11052792"]}, {"Citation": "Muegge I, Heald SL, Brittelli D. Simple selection criteria for drug-like chemical matter. J Med Chem. 2001;44:1841-1846.", "ArticleIdList": ["11384230"]}, {"Citation": "Omidkhah N, Hadizadeh F, Zarghi A, Ghodsi R. Synthesis, cytotoxicity, Pan-HDAC inhibitory activity and docking study of new N-(2-aminophenyl)-2-methylquinoline-4-carboxamide and (E)-N-(2-aminophenyl)-2-styrylquinoline-4-carboxamide derivatives as anticancer agents. Med Chem Res. 2024;32:506-524."}, {"Citation": "Mukhtar M, Khan HA, Zaidi NUSS. Exploring the inhibitory potential of Nigella sativa against dengue virus NS2B/NS3 protease and NS5 polymerase using computational approaches. RSC Adv. 2023;13:18306-18322. doi:10.1039/d3ra02613b", "ArticleIdList": ["10.1039/d3ra02613b", "PMC10273825", "37333789"]}, {"Citation": "Ayob AZ, Ramasamy TS. Cancer stem cells as key drivers of tumour progression. J Biomed Sci. 2018;25:1-18.", "ArticleIdList": ["PMC5838954", "29506506"]}, {"Citation": "Asgaonkar K, Tanksali S, Abhang K, Sagar A. Development of optimized pyrimido-thiazole scaffold derivatives as anticancer and multitargeting tyrosine kinase inhibitors using computational studies. J Indian Chem Soc. 2023;100:100803."}, {"Citation": "Barazorda-Ccahuana HL, Jr, Galvez Ranilla L, Jr, Candia-Puma MA, Jr, et al.. PeruNPDB: the Peruvian Natural Products Database for in silico drug screening. Sci Rep. 2023;13:7577.", "ArticleIdList": ["PMC10170056", "37165197"]}, {"Citation": "Nagu P, Pathan AKA, Mehta V. Screening of herbal molecules for the management of Alzheimer\u2019s disorder through molecular docking and in-vitro investigation. bioRxiv. Published online January 2, 2023. doi:10.1101/2023.01.01.522412", "ArticleIdList": ["10.1101/2023.01.01.522412"]}, {"Citation": "Gani MA, Nurhan AD, Hadinar Putri BRK, et al.. Computational approach in searching for dual action multitarget inhibitors for osteosarcoma. J Adv Pharm Technol Res. 2023;14:18-23.", "ArticleIdList": ["PMC10026319", "36950466"]}, {"Citation": "Pettersen EF, Goddard TD, Huang CC, et al.. UCSF ChimeraX: structure visualization for researchers, educators, and developers. Protein Sci. 2021;30:70-82.", "ArticleIdList": ["PMC7737788", "32881101"]}, {"Citation": "Goddard TD, Huang CC, Meng EC, et al.. UCSF ChimeraX: meeting modern challenges in visualization and analysis. Protein Sci. 2018;27:14-25.", "ArticleIdList": ["PMC5734306", "28710774"]}, {"Citation": "\nBiovia Discovery Studio. Discovery Studio 2020. Published 2020.https://discover.3ds.com/discovery-studio-visualizer-download"}, {"Citation": "Van Der Spoel D, Lindahl E, Hess B, Groenhof G, Mark AE, Berendsen HJ. GROMACS: fast, flexible, and free. J Comput Chem. 2005;26:1701-1718.", "ArticleIdList": ["16211538"]}, {"Citation": "Jo S, Kim T, Iyer VG, Im W. CHARMM-GUI: a web-based graphical user interface for CHARMM. J Comput Chem. 2008;29:1859-1865.", "ArticleIdList": ["18351591"]}, {"Citation": "Michaud-Agrawal N, Denning EJ, Woolf TB, Beckstein O. MDAnalysis: a toolkit for the analysis of molecular dynamics simulations. J Comput Chem. 2011;32:2319-2327.", "ArticleIdList": ["PMC3144279", "21500218"]}, {"Citation": "Nakamura T, Isoda N, Sakoda Y, Harashima H. Strategies for fighting pandemic virus infections: integration of virology and drug delivery. J Control Release. 2022;343:361-378.", "ArticleIdList": ["PMC8810279", "35122872"]}, {"Citation": "Paul A, Chakraborty N, Sarkar A, et al.. Ethnopharmacological potential of phytochemicals and phytogenic products against human RNA viral diseases as preventive therapeutics. Biomed Res Int. 2023;2023:1977602.", "ArticleIdList": ["PMC9970710", "36860811"]}, {"Citation": "Shimu MSS, Mahmud S, Tallei TE, et al.. Phytochemical compound screening to identify novel small molecules against dengue virus: a docking and dynamics study. Molecules. 2022;27:653. doi:10.3390/molecules27030653", "ArticleIdList": ["10.3390/molecules27030653", "PMC8840231", "35163918"]}, {"Citation": "Sofowora A, Ogunbodede E, Onayade A. The role and place of medicinal plants in the strategies for disease prevention. Afr J Tradit Complement Altern Med. 2013;10:210-229.", "ArticleIdList": ["PMC3847409", "24311829"]}, {"Citation": "Chakraborty N, Banerjee A, Sarkar A, Ghosh S, Acharya K. Mushroom polysaccharides: a potent immune-modulator. Biointerface Res Appl Chem. 2021;11:8915-8930."}, {"Citation": "Anjum N, Ridwan Q, Akhter F, Hanief M. Phytochemistry and therapeutic potential of Berberis lycium Royle; an endangered species of Himalayan region. Acta Ecol Sin. 2022;43:577-584. doi:10.1016/j.chnaes.2022.09.005", "ArticleIdList": ["10.1016/j.chnaes.2022.09.005"]}, {"Citation": "Parra SA, Gaur K, Ranawat LS, Rather MI. An overview on various aspects of plant Berberis lycium Royale. Am J Pharmacol Sci. 2018;6:19-24."}, {"Citation": "Katare AK, Singh B, Shukla P, et al.. Rapid determination and optimisation of berberine from Himalayan Berberis lycium by soxhlet apparatus using CCD-RSM and its quality control as a potential candidate for COVID-19. Nat Prod Res. 2022;36:868-873.", "ArticleIdList": ["32787584"]}, {"Citation": "Ilieva Y, Kokanova-Nedialkova Z, Nedialkov P, Momekov G. In silico ADME and drug-likeness evaluation of a series of cytotoxic polyprenylated acylphloroglucinols, isolated from Hypericum annulatum Morris subsp. annulatum. Bulg Chem Commun. 2018;50:193-199."}, {"Citation": "Chandran K, Shane DI, Zochedh A, Sultan AB, Kathiresan T. Docking simulation and ADMET prediction based investigation on the phytochemical constituents of Noni (Morinda citrifolia) fruit as a potential anticancer drug. In Silico Pharmacol. 2022;10:14.", "ArticleIdList": ["PMC9411403", "36034317"]}, {"Citation": "Udugade S, Doijad R, Udugade B. In silico evaluation of pharmacokinetics, drug-likeness and medicinal chemistry friendliness of momordicin1: an active chemical constituent of Momordica charantia. J Adv Sci Res. 2019;10:222-229."}, {"Citation": "Sarkar P, Srivastava V, Ailani K. Molecular docking simulation, drug pharmacokinetics and synthesis of carbon nanodots from phytochemicals against isoenzymes of cancer. Mater Today Proc. 2023;76:289-302."}, {"Citation": "Bouachrine M, Elmchichi L, El Aissouq A, et al.. Molecular docking, drug likeness studies and ADMET prediction of flavonoids as platelet-activating factor (PAF) receptor binding. Chem Rev Lett. 2021;4:145-152."}, {"Citation": "Mahmud S, Paul GK, Biswas S, et al.. Phytochemdb: a platform for virtual screening and computer-aided drug designing. Database. 2022;2022:baac002.", "ArticleIdList": ["PMC9255273", "35234849"]}, {"Citation": "Preman G, Mulani M, Bare A, et al.. Virtual screening of phytochemicals for anti-tubercular potential using molecular docking approach. J Tuberc. 2022;5:1030."}, {"Citation": "Rahmadani K, Manguntungi B, Arwansyah A, et al.. Efficiency of nitrification inhibitor on designing nitrogen fertilizer by neem compounds based on molecular docking. Trends Sci. 2023;20:6395-6395."}, {"Citation": "G\u00fcnay MG, Kemerli U, Karaman C, Karaman O, G\u00fcng\u00f6r A, Karimi-Maleh H. Review of functionalized nano porous membranes for desalination and water purification: MD simulations perspective. Environ Res. 2023;217:114785.", "ArticleIdList": ["36395866"]}, {"Citation": "Tripathi N, Bandyopadhyay A. Virtual screening of knottin and defensin peptides perceives hits against the SARS CoV-2 RBD domain and hACE2 interaction. ChemRxiv. Published online January 18, 2023. doi:10.26434/chemrxiv-2023-5p74j", "ArticleIdList": ["10.26434/chemrxiv-2023-5p74j"]}, {"Citation": "\nGowers RJ, Linke M, Barnoud J, et al.. MDAnalysis: a Python package for the rapid analysis of molecular dynamics simulations. Paper presented at: Scipy; July 11, 2016:105; Austin, TX. https://www.osti.gov/servlets/purl/1565806."}, {"Citation": "Tope Abraham I, Ayodele Ifeoluwa F, Peace Ifeoma O, et al.. Ethnomedicine claim directed in-silico prediction of epidermal growth factor receptor kinase antagonist: an untapped reservoir of prospective anticancer agents. World J Adv Res Rev. 2023;17:662-669. doi:10.30574/wjarr.2023.17.1.0088", "ArticleIdList": ["10.30574/wjarr.2023.17.1.0088"]}, {"Citation": "Al-Khafaji K, Taskin Tok T. Molecular dynamics simulation, free energy landscape and binding free energy computations in exploration the anti-invasive activity of amygdalin against metastasis. Comput Methods Programs Biomed. 2020;195:105660.", "ArticleIdList": ["32726718"]}, {"Citation": "\u015aled\u017a P, Caflisch A. Protein structure-based drug design: from docking to molecular dynamics. Curr Opin Struct Biol. 2018;48:93-102.", "ArticleIdList": ["29149726"]}, {"Citation": "Ibrahim MA, Abdeljawaad KA, Roshdy E, et al.. In silico drug discovery of SIRT2 inhibitors from natural source as anticancer agents. Sci Rep. 2023;13:2146.", "ArticleIdList": ["PMC9905574", "36750593"]}, {"Citation": "Pande M, Kundu D, Srivastava R. Selective vitamins as potential options for dietary therapeutic interventions: in silico and in vitro insights from mutant C terminal fragment of FGA. J Steroid Biochem Mol Biol. 2023;230:106290.", "ArticleIdList": ["36907427"]}, {"Citation": "Lee Y, Lazim R, Macalino SJY, Choi S. Importance of protein dynamics in the structure-based drug discovery of class AG protein-coupled receptors (GPCRs). Curr Opin Struct Biol. 2019;55:147-153.", "ArticleIdList": ["31102980"]}]}], "History": [{"Year": "2023", "Month": "11", "Day": "5"}, {"Year": "2024", "Month": "6", "Day": "6"}, {"Year": "2024", "Month": "7", "Day": "29", "Hour": "6", "Minute": "43"}, {"Year": "2024", "Month": "7", "Day": "29", "Hour": "6", "Minute": "42"}, {"Year": "2024", "Month": "7", "Day": "29", "Hour": "5", "Minute": "55"}, {"Year": "2024", "Month": "7", "Day": "27"}], "PublicationStatus": "epublish", "ArticleIdList": ["39072259", "PMC11283669", "10.1177/11779322241264144", "10.1177_11779322241264144"]}}]}